Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS
Content archived on 2024-04-30

Potential antifibrotic role of natriuretic peptides and nitric oxide in the heart

Objective



Disproportionate collagen deposition in the heart impairs cardiac function and may contribute significantly to the poor prognosis of cardiac hypertrophy. Although there has been considerable work elucidating humoral factors which promote myocardial fibrosis much less is known about antifibrotic mechanisms. We propose that atrial and brain natriuretic peptide (ANP and BNP) and nitric oxide (NO) antagonise the effects of fibrotic factors in the myocardium. To address this hypothesis we will: (i) establish the natriuretic peptide receptor subtypes expressed by cardiac fibroblasts; (ii) compare changes in the expression of these subtypes and nitric oxide synthase in cardiac tissue from animal models of cardiac hypertrophy with and without myocardial fibrosis; (iii) examine the effect of ANP, BNP and NO donors on cardiac fibroblast proliferation and collagen synthesis 'in vitro'; and (iv) investigate the effect of a combined neutral- endopeptidase/angiotensin-converting enzyme inhibitor on collagen deposition in the heart 'in vivo'. These studies will provide valuable insight into the role of ANP, BNP and NO in regulating cardiac remodelling and their potential therapeutic value in the treatment of cardiac hypertrophy.

Fields of science (EuroSciVoc)

Programme(s)

Topic(s)

Call for proposal

Data not available

Funding Scheme

RGI - Research grants (individual fellowships)

Coordinator

Royal Postgraduate Medical School
EU contribution
No data
Address
Du Cane Road
W12 0NN London
United Kingdom
Total cost
No data

Participants (1)